Molecular 'feedback loop' may explain tamoxifen resistance in patients with breast ca

[News]

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer...

More... (http://www.medicalnewstoday.com/releases/300004.php)